Doctors successfully treated a baby with the first ever personalized gene-editing therapy

A team of doctors and scientists have successfully treated a rare genetic condition with the first-ever personalized gene-editing therapy. Results of the groundbreaking treatment have been published i [...]

CRISPR can stop malaria spread by editing a single gene in mosquitos

CRISPR gene-editing therapy has shown great potential to treat and even cure diseases, but scientists are now discovering how it can be used to prevent them as well. A team of researchers found a way [...]

Deepmind dismantles its AlphaFold team as key authors leave for Anthropic

The majority of the researchers behind AlphaFold are now working on other projects, and almost a quarter have left Google Deepmind altogether. The restructuring marks a sharp turn away from the strate [...]

AI consultant uses ChatGPT, AlphaFold, and Grok to find a possible treatment for his dog's cancer

An Australian AI consultant used ChatGPT, AlphaFold, and Grok to find a possible treatment for his dog Rosie's incurable cancer. The story went viral after high-profile AI executives like OpenAI& [...]

DeepMind won a Nobel for AlphaFold. Then it broke up the team.

Less than a year ago, AlphaFold won Google DeepMind a Nobel Prize. Now DeepMind has taken the team that built it apart. The lab has reassigned most of the original AlphaFold-paper authors over the pas [...]

Isomorphic Labs prepares for its first human trials with drugs designed by AlphaFold

Isomorphic Labs, a Deepmind spin-off focused on drug discovery, is getting ready for its first clinical trials with drugs designed using AlphaFold-based AI models.<br /> The article Isomorphic L [...]

Google's AI drug discovery spinoff Isomorphic Labs claims major leap beyond AlphaFold 3

Isomorphic Labs, Google DeepMind's AI medicine startup, has unveiled a new system called "Isomorphic Labs Drug Design Engine" (IsoDDE) that it says doubles AlphaFold 3's accuracy f [...]

Nobel laureate John Jumper is leaving Google DeepMind for Anthropic after nearly nine years

John Jumper, the Google DeepMind vice president who won the 2024 Nobel Prize in Chemistry for creating AlphaFold, is leaving the company after nearly nine years to join Anthropic. Jumper announced the [...]

Clinical trial shows gene editing works for β-Thalassaemia, too

Improved gene editing process reactivates the fetal version of a hemoglobin gene. [...]